Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             52 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIVmac251 challenge in Rhesus Macaques Muthumani, Karuppiah
2003
21 7-8 p. 629-637
9 p.
artikel
2 Anti-cancer therapy using dendritic cells and apoptotic tumour cells: pre-clinical data in human mesothelioma and acute myeloid leukaemia Grégoire, M.
2003
21 7-8 p. 791-794
4 p.
artikel
3 Bioterrorism and the biotechnologist Spier, R.E
2003
21 7-8 p. 582-585
4 p.
artikel
4 Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults Zent, Olaf
2003
21 7-8 p. 738-741
4 p.
artikel
5 Contribution of dead cells to the immunogenicity of an autologous, hapten-modified melanoma vaccine Berd, David
2003
21 7-8 p. 795-797
3 p.
artikel
6 Corn as a production system for human and animal vaccines Streatfield, Stephen J
2003
21 7-8 p. 812-815
4 p.
artikel
7 Costs and benefits of polio eradication: a long-run global perspective Khan, M.Mahmud
2003
21 7-8 p. 702-705
4 p.
artikel
8 Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C12U] (Ampligen®) Adams, M
2003
21 7-8 p. 787-790
4 p.
artikel
9 Development of surrogate markers for oral immunisation against Candida albicans Elahi, Shokrollah
2003
21 7-8 p. 671-677
7 p.
artikel
10 Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine Salleras, L.
2003
21 7-8 p. 729-733
5 p.
artikel
11 Editorial Board/Aims and Scope 2003
21 7-8 p. IFC-
1 p.
artikel
12 Effectiveness of a mass hepatitis A vaccination program in preadolescents Domı́nguez, Àngela
2003
21 7-8 p. 698-701
4 p.
artikel
13 Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b de Melker, H.E
2003
21 7-8 p. 716-720
5 p.
artikel
14 Experience with registered mucosal vaccines Dietrich, Guido
2003
21 7-8 p. 678-683
6 p.
artikel
15 Fourth World Congress on Vaccines and Immunisation, September 29–October 3 2004, Tsukuba Science City, Japan 2003
21 7-8 p. I-
1 p.
artikel
16 Functional mapping of protective epitopes within the rotavirus VP6 protein in mice belonging to different haplotypes Choi, Anthony H.-C.
2003
21 7-8 p. 761-767
7 p.
artikel
17 Human rabies prophylactics: the French experience Rotivel, Y
2003
21 7-8 p. 710-715
6 p.
artikel
18 Immunity under the skin: potential application for topical delivery of vaccines Partidos, C.D.
2003
21 7-8 p. 776-780
5 p.
artikel
19 Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella Xu, Fengfeng
2003
21 7-8 p. 644-648
5 p.
artikel
20 Immunogenic measles antigens expressed in plants: role as an edible vaccine for adults Muller, Claude P
2003
21 7-8 p. 816-819
4 p.
artikel
21 Impact of mass vaccination with polysaccharide conjugate vaccine against serogroup C meningococcal disease in Spain Salleras, L.
2003
21 7-8 p. 725-728
4 p.
artikel
22 Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy Bonanni, Paolo
2003
21 7-8 p. 685-691
7 p.
artikel
23 Induction of immune responses by DNA vaccines in large animals Babiuk, L.A
2003
21 7-8 p. 649-658
10 p.
artikel
24 Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments Dietrich, Guido
2003
21 7-8 p. 667-670
4 p.
artikel
25 New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund Martin, Jacques-François
2003
21 7-8 p. 587-592
6 p.
artikel
26 Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems Glück, R
2003
21 7-8 p. 611-615
5 p.
artikel
27 Options for improvement of the Dutch measles vaccination schedule van den Hof, S
2003
21 7-8 p. 721-724
4 p.
artikel
28 Preface Kurstak, Edouard
2003
21 7-8 p. 579-
1 p.
artikel
29 Primary prevention of hepatitis C virus infection Zanetti, Alessandro R
2003
21 7-8 p. 692-695
4 p.
artikel
30 Priming characteristics of peptide mimotopes of carbohydrate antigens Monzavi-Karbassi, Behjatolah
2003
21 7-8 p. 753-760
8 p.
artikel
31 Production of antibodies in plants and their use for global health Fischer, Rainer
2003
21 7-8 p. 820-825
6 p.
artikel
32 Progress in DNA vaccine for prophylaxis and therapy of hepatitis B Thermet, Alexandre
2003
21 7-8 p. 659-662
4 p.
artikel
33 Prospects and challenges for prophylactic and therapeutic HIV vaccines Klein, Michel
2003
21 7-8 p. 616-619
4 p.
artikel
34 Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing protective listerial epitopes within a surface-exposed loop of the TolC-protein Spreng, Simone
2003
21 7-8 p. 746-752
7 p.
artikel
35 Recent progress in the development of vaccines for infants and children McIntosh, E.David G
2003
21 7-8 p. 601-604
4 p.
artikel
36 Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease Holst, J
2003
21 7-8 p. 734-737
4 p.
artikel
37 Targeting of plant-derived vaccine antigens to immunoresponsive mucosal sites Rigano, M.Manuela
2003
21 7-8 p. 809-811
3 p.
artikel
38 The challenge to provide affordable rabies post-exposure treatment Warrell, Mary J
2003
21 7-8 p. 706-709
4 p.
artikel
39 The global value of vaccination Ehreth, Jenifer
2003
21 7-8 p. 596-600
5 p.
artikel
40 Therapeutic vaccination for future management of HIV/AIDS Lisziewicz, Julianna
2003
21 7-8 p. 620-623
4 p.
artikel
41 The rationale of a peptide-conjugate vaccine against measles Pütz, Mike M
2003
21 7-8 p. 663-666
4 p.
artikel
42 Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN “NEW” in children: results of post-marketing surveillance Pavlova, Borislava G.
2003
21 7-8 p. 742-745
4 p.
artikel
43 Towards new immunotherapies: targeting recombinant cytokines to the immune system using live attenuated Salmonella Rosenkranz, Claudia D
2003
21 7-8 p. 798-801
4 p.
artikel
44 Towards the new global vaccinology era in prevention and control of diseases Kurstak, Prof.Dr.Edouard
2003
21 7-8 p. 580-581
2 p.
artikel
45 Transcriptome-based antigen identification for Neisseria meningitidis Kurz, Sebastian
2003
21 7-8 p. 768-775
8 p.
artikel
46 Tumor antigen-specific T cells and cancer immunotherapy: current issues and future prospects Kalos, Michael
2003
21 7-8 p. 781-786
6 p.
artikel
47 Two years into reverse vaccinology Adu-Bobie, Jeannette
2003
21 7-8 p. 605-610
6 p.
artikel
48 Vaccination strategies against hepatitis A in southern Europe Franco, Elisabetta
2003
21 7-8 p. 696-697
2 p.
artikel
49 Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives Sala, Francesco
2003
21 7-8 p. 803-808
6 p.
artikel
50 Vaccinology: past achievements, present roadblocks and future promises André, Francis E
2003
21 7-8 p. 593-595
3 p.
artikel
51 V-1 Immunitor: oral therapeutic AIDS vaccine with prophylactic potential Jirathitikal, Vichai
2003
21 7-8 p. 624-628
5 p.
artikel
52 Virus-like particle and DNA-based candidate AIDS vaccines Yao, Qizhi
2003
21 7-8 p. 638-643
6 p.
artikel
                             52 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland